These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

117 related articles for article (PubMed ID: 28833080)

  • 1. Non-invasive monitoring of the cardiac effects of continuous intravenous oxytocin infusion during cesarean delivery.
    Tanaka H; Tanaka K; Tsuji M; Magawa S; Hatano F; Nii M; Ikeda T
    Int J Gynaecol Obstet; 2017 Nov; 139(2):251-252. PubMed ID: 28833080
    [No Abstract]   [Full Text] [Related]  

  • 2. Oxytocin protocols for cesarean delivery.
    Balki M; Tsen L
    Int Anesthesiol Clin; 2014; 52(2):48-66. PubMed ID: 24667448
    [No Abstract]   [Full Text] [Related]  

  • 3. Rectally administered misoprostol versus intravenous oxytocin infusion during cesarean delivery to reduce intraoperative and postoperative blood loss.
    Chaudhuri P; Banerjee GB; Mandal A
    Int J Gynaecol Obstet; 2010 Apr; 109(1):25-9. PubMed ID: 20070961
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of a High-Rate Versus a Low-Rate Oxytocin Infusion for Maintaining Uterine Contractility During Elective Cesarean Delivery: A Prospective Randomized Clinical Trial.
    Duffield A; McKenzie C; Carvalho B; Ramachandran B; Yin V; El-Sayed YY; Riley ET; Butwick AJ
    Anesth Analg; 2017 Mar; 124(3):857-862. PubMed ID: 28212181
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Sublingual misoprostol versus oxytocin infusion to reduce blood loss at cesarean section.
    Vimala N; Mittal S; Kumar S
    Int J Gynaecol Obstet; 2006 Feb; 92(2):106-10. PubMed ID: 16343498
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Survey on the use of oxytocin for cesarean section.
    Marcus HE; Fabian A; Lier H; Dagtekin O; Böttiger BW; Teschendorf P; Petzke F; Valter M; Spöhr F
    Minerva Anestesiol; 2010 Nov; 76(11):890-5. PubMed ID: 20592672
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Impact of dose-finding studies on administration of oxytocin during caesarean section in the UK.
    West R; West S; Simons R; McGlennan A
    Anaesthesia; 2013 Oct; 68(10):1021-5. PubMed ID: 23944710
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Up-down determination of the ED(90) of oxytocin infusions for the prevention of postpartum uterine atony in parturients undergoing Cesarean delivery.
    George RB; McKeen D; Chaplin AC; McLeod L
    Can J Anaesth; 2010 Jun; 57(6):578-82. PubMed ID: 20238255
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prophylactic use of oxytocin at caesarean section: where are the guidelines?
    Weale N; Laxton C
    Anaesthesia; 2013 Oct; 68(10):1006-9. PubMed ID: 23944657
    [No Abstract]   [Full Text] [Related]  

  • 10. Minimum effective bolus dose of oxytocin during elective Caesarean delivery.
    Breeze E
    Br J Anaesth; 2010 Jun; 104(6):783; author reply 783-5. PubMed ID: 20460573
    [No Abstract]   [Full Text] [Related]  

  • 11. Maternal haemodynamics at elective caesarean section: a randomised comparison of oxytocin 5-unit bolus and placebo infusion with oxytocin 5-unit bolus and 30-unit infusion.
    McLeod G; Munishankar B; MacGregor H; Murphy DJ
    Int J Obstet Anesth; 2010 Apr; 19(2):155-60. PubMed ID: 20194013
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Intravenous oxytocin in patients undergoing elective cesarean section.
    Zarzur E
    Anesth Analg; 1998 Jun; 86(6):1334. PubMed ID: 9620531
    [No Abstract]   [Full Text] [Related]  

  • 13. Haemodynamic effects of oxytocin given as i.v. bolus or infusion on women undergoing Caesarean section.
    Thomas JS; Koh SH; Cooper GM
    Br J Anaesth; 2007 Jan; 98(1):116-9. PubMed ID: 17142825
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Five unit bolus oxytocin at cesarean delivery in women at risk of atony: a randomized, double-blind, controlled trial.
    King KJ; Douglas MJ; Unger W; Wong A; King RA
    Anesth Analg; 2010 Dec; 111(6):1460-6. PubMed ID: 20889945
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Sublingual misoprostol versus intravenous oxytocin in reducing bleeding during and after cesarean delivery: A randomized clinical trial.
    Othman ER; Fayez MF; El Aal DE; El-Dine Mohamed HS; Abbas AM; Ali MK
    Taiwan J Obstet Gynecol; 2016 Dec; 55(6):791-795. PubMed ID: 28040121
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Oxytocin for labour and caesarean delivery: implications for the anaesthesiologist.
    Dyer RA; Butwick AJ; Carvalho B
    Curr Opin Anaesthesiol; 2011 Jun; 24(3):255-61. PubMed ID: 21415725
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The Effect of the Combined Use of Methylergonovine and Oxytocin during Caesarean Section in the Prevention of Post-partum Haemorrhage.
    Şentürk Ş; Kağıtçı M; Balık G; Arslan H; Kır Şahin F
    Basic Clin Pharmacol Toxicol; 2016 May; 118(5):338-43. PubMed ID: 26449959
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The effect of sublingual misoprostol versus intravenous oxytocin in reducing bleeding after caesarean section.
    Eftekhari N; Doroodian M; Lashkarizadeh R
    J Obstet Gynaecol; 2009 Oct; 29(7):633-6. PubMed ID: 19757270
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effect of sublingual misoprostol versus intravenous oxytocin on reducing blood loss at cesarean section in Nigeria: a randomized controlled trial.
    Owonikoko KM; Arowojolu AO; Okunlola MA
    J Obstet Gynaecol Res; 2011 Jul; 37(7):715-21. PubMed ID: 21375669
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Intravenous oxytocin bolus of 2 units is superior to 5 units during elective Caesarean section.
    Sartain JB; Barry JJ; Howat PW; McCormack DI; Bryant M
    Br J Anaesth; 2008 Dec; 101(6):822-6. PubMed ID: 18845650
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.